Balchem (NASDAQ:BCPC – Get Free Report) and General Enterprise Ventures (OTCMKTS:GEVI – Get Free Report) are both basic materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, valuation, risk, dividends and analyst recommendations.
Risk and Volatility
Balchem has a beta of 0.69, indicating that its share price is 31% less volatile than the S&P 500. Comparatively, General Enterprise Ventures has a beta of 5.33, indicating that its share price is 433% more volatile than the S&P 500.
Insider & Institutional Ownership
87.9% of Balchem shares are owned by institutional investors. 1.3% of Balchem shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Balchem | 12.90% | 10.99% | 7.65% |
| General Enterprise Ventures | -544.66% | -162.24% | -104.56% |
Valuation and Earnings
This table compares Balchem and General Enterprise Ventures”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Balchem | $922.44 million | 5.67 | $108.54 million | $3.72 | 43.25 |
| General Enterprise Ventures | $520,000.00 | 47.42 | -$10.10 million | ($0.08) | -8.38 |
Balchem has higher revenue and earnings than General Enterprise Ventures. General Enterprise Ventures is trading at a lower price-to-earnings ratio than Balchem, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of current recommendations for Balchem and General Enterprise Ventures, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Balchem | 0 | 0 | 1 | 0 | 3.00 |
| General Enterprise Ventures | 0 | 0 | 0 | 0 | 0.00 |
Balchem presently has a consensus price target of $190.00, indicating a potential upside of 18.09%. Given Balchem’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Balchem is more favorable than General Enterprise Ventures.
Summary
Balchem beats General Enterprise Ventures on 11 of the 13 factors compared between the two stocks.
About Balchem
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
About General Enterprise Ventures
General Enterprise Ventures, Inc., engages in installing large home and facility proactive wildfire prevention systems. It offers CitroTech products for the prevention and spread of wildfires, as well as lumber treatments for fire prevention. The company was formerly known as General Entertainment Ventures, Inc. and changed its name to General Enterprise Ventures, Inc. in October 2021. General Enterprise Ventures, Inc. is based in Cheyenne, Wyoming.
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.
